The use of the tumour necrosis factor antagonist infliximab in heart transplant recipients: Two case reports [4]

Annals of the Rheumatic Diseases

Volumn 66, Issue 11, 2007, Pages 1544-1545

  Metyas, S ^a   La, D ^a   Arkfeld, D G ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB;

ADJUVANT CHEMOTHERAPY; ADULT; CASE REPORT; COLON CANCER; DECUBITUS; DRUG RESPONSE; DRUG WITHDRAWAL; FEMALE; GRAFT RECIPIENT; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; LETTER; MALE; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; TUMOR NECROSIS FACTOR-ALPHA;

EID: 35648965804     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2007.070383     Document Type: Letter

References (8)

1. Anker SD, Coats AJS. How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH. Int J Cardiol 2002;86:123-30.
2. Torre-Amione G, Kapadia S, Benedict C, et al. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 1996;27:1201-6.
3. Ferrari R, Bachetti T, Confortini R, et al. Tumour necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 1995;92:1479-86.
4. Deswal A, Petersen NJ, Feldman AM, et al. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 2001;103:2055-9.
5. Rauchhaus M, Doehner W, Francis DP, et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 2000;102:3060-7.
6. Yokoyama T, Vaca L, Rossen RD, et al. Cellular basis for the negative inotropic effects of tumour necrosis factor-alpha in the adult mammalian heart. J Clin Invest 1993;92:2303-12.
7. Mandi Y, Hogye M, Talha EM, et al. Cytokine production and antibodies against heat shock protein 60 in cardiomyopathies of different origins. Pathobiology 2000;68:150-8.
8. Abdallah AN, Billes MA, Attia Y, et al. Evaluation of plasma levels of tumour necrosis factor alpha and interleukin-6 as rejection markers in a cohort of 142 heart-grafted patients followed by endomyocardial biopsy. Eur Heart J 1997;18:1024-9.